Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on May 04, 2023 1:09pm
316 Views
Post# 35430471

It will be months before Tetra trades again IF ever !

It will be months before Tetra trades again IF ever ! March 1st, 2023
The Company also announced PwC (PricewaterhouseCoopers LLP) has resigned as auditors and are now working with McGovern Hurley LLP to complete the preparation of these filings and expects to file its 2022 annual financial statements and related management's discussion and analysis on or before April 15, 2023.
PwC LLP doesn't work for nothing the way shareholders have for the past 5 years .Zero communication , I am thinking Tetra is stalling and they do not want to disclose how much debt Tetra really has outstanding , no communication from the company what so ever, it takes two weeks normally to produce financials. They are stalling ! Trading at .01 and no volume to speak of. There are also additional daily penalties for not trading and if they have do produce statements there will be an application reinstatement fees to trade again, I don't believe Guy will spend any of his 5 million plus he got from Aphria or  the 500,000 a year he got from running Tetra into the ground .Droninabol still sitting at number 5 with 8 covid priority so really in 13th spot with zero updates , May 4th , 2023 today.I don't think Guy plans on saving Tetra for the shareholders, its all about him and his science not the shareholders , we were all just used for his bank.
<< Previous
Bullboard Posts
Next >>